264 related articles for article (PubMed ID: 27873492)
1. Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
Sung HY; Yang SD; Park AK; Ju W; Ahn JH
Yonsei Med J; 2017 Jan; 58(1):27-34. PubMed ID: 27873492
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
Sung HY; Park AK; Ju W; Ahn JH
Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
Sung HY; Han J; Ju W; Ahn JH
Oncol Rep; 2016 Jul; 36(1):535-41. PubMed ID: 27220283
[TBL] [Abstract][Full Text] [Related]
4. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.
Sung HY; Yang SD; Ju W; Ahn JH
Exp Mol Med; 2017 May; 49(5):e335. PubMed ID: 28524180
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.
Sung HY; Ju W; Ahn JH
Yonsei Med J; 2014 Nov; 55(6):1656-63. PubMed ID: 25323905
[TBL] [Abstract][Full Text] [Related]
6. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer.
Kim NH; Sung HY; Choi EN; Lyu D; Choi HJ; Ju W; Ahn JH
Oncol Rep; 2014 May; 31(5):2139-46. PubMed ID: 24676393
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.
Izutsu N; Maesawa C; Shibazaki M; Oikawa H; Shoji T; Sugiyama T; Masuda T
Int J Oncol; 2008 Jun; 32(6):1227-35. PubMed ID: 18497984
[TBL] [Abstract][Full Text] [Related]
11. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells.
Sung HY; Choi EN; Lyu D; Park AK; Ju W; Ahn JH
Oncol Rep; 2014 Aug; 32(2):815-20. PubMed ID: 24920423
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.
Burton ER; Gaffar A; Lee SJ; Adeshuko F; Whitney KD; Chung JY; Hewitt SM; Huang GS; Goldberg GL; Libutti SK; Kwon M
Mol Cancer Res; 2011 Aug; 9(8):1126-38. PubMed ID: 21693594
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.
de Leon M; Cardenas H; Vieth E; Emerson R; Segar M; Liu Y; Nephew K; Matei D
Gynecol Oncol; 2016 Sep; 142(3):539-47. PubMed ID: 27374141
[TBL] [Abstract][Full Text] [Related]
16. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.
Sakuma M; Akahira J; Ito K; Niikura H; Moriya T; Okamura K; Sasano H; Yaegashi N
Cancer Sci; 2007 Mar; 98(3):380-6. PubMed ID: 17270028
[TBL] [Abstract][Full Text] [Related]
18. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.
Akahira J; Sugihashi Y; Suzuki T; Ito K; Niikura H; Moriya T; Nitta M; Okamura H; Inoue S; Sasano H; Okamura K; Yaegashi N
Clin Cancer Res; 2004 Apr; 10(8):2687-93. PubMed ID: 15102672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
